High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery

Cancer

Volumn 119, Issue 5, 2013, Pages 993-1003

  Shi, Ruo Yu ^a,b   Yang, Xin Rong ^a,b   Shen, Qiu Jin ^c   Yang, Liu Xiao ^a,b   Xu, Yang ^a,b   Qiu, Shuang Jian ^a,b   Sun, Yun Fan ^a,b   Zhang, Xin ^a,b   Wang, Zheng ^a,b   Zhu, Kai ^a,b   Qin, Wen Xin ^c   Tang, Zhao You ^a,b   Fan, Jia ^a,b   Zhou, Jian ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dickkopf related protein 1; intrahepatic cholangiocarcinoma; lymphatic metastasis; matrix metalloproteinase 9; prognosis; vascular endothelial growth factor C

Indexed keywords

DICKKOPF 1 PROTEIN; GELATINASE B; SMALL INTERFERING RNA; VASCULOTROPIN C;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG HILUS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK; TISSUE MICROARRAY; WESTERN BLOTTING;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84874279197     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27788     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global Cancer Statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2009; 135: 1073-1080.
3. Shaib YH, Davila JA, McGlynn K, El-Serag HB,. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004; 40: 472-477.
4. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. Cholangiocarcinoma. Lancet. 2005; 366: 1303-1314.
5. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocardnoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008; 248: 84-96.
6. Khan SA, Davidson BR, Goldin R, et al., British Society of Gastroenterology,. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002; 51 (suppl 6): VI1-VI9.
7. Iguchi T, Aishima S, Taketomi A, et al. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Human Pathol. 2009; 40: 174-180.
8. Huang XY, Ke AW, Shi GM, et al. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer. 2010; 116: 5440-5451.
9. Larbcharoensub N, Sornmayura P, Sirachainan E, Wilasrusmee C, Wanmoung H, Janvilisri T,. Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma. Histopathology. 2011; 59: 235-246.
10. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C,. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998; 391: 357-362.
11. Kazanskaya O, Glinka A, Niehrs C,. The role of Xenopus dickkopf1 in prechordal plate specification and neural patterning. Development. 2000; 127: 4981-4992.
12. Forget MA, Turcotte S, Beauseigle D, et al. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer. 2007; 96: 646-653.
13. Yamabuki T, Takano A, Hayama S, et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res. 2007; 67: 2517-2525.
14. Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE,. FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J. 2005; 24: 73-84.
15. Tian E, Zhan FH, Walker R, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003; 349: 2483-2494.
16. Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H,. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer. 2010; 126: 1611-1620.
17. Yu B, Yang X, Xu Y, et al. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol. 2009; 50: 948-957.
18. Sato N, Yamabuki T, Takano A, et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010; 70: 5326-5336.
19. Qian J, Xie J, Hong S, et al. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood. 2007; 110: 1587-1594.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th edition. New York, NY: Springer; 2010.
21. Yang XR, Xu Y, Yu B, et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res. 2009; 15: 5518-5527.
22. Park BK, Paik YH, Park JY, et al. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol. 2006; 29: 138-142.
23. Onodera M, Zen Y, Harada K, et al. Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest. 2009; 89: 1261-1274.
24. Li JC, Yang XR, Sun HX, et al. Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology. 2010; 139: 2146-2475.
25. Zhao YM, Wang L, Dai Z, et al. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. Int J Cancer. 2011; 129: 2463-2472.
26. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011; 29: 3140-3145.
27. Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer. 2011; 117: 2170-2177.
28. Aishima S, Nishihara Y, Iguchi T, et al. Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol. 2008; 21: 256-264.
29. Tanioka Y, Yoshida T, Yagawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer. 2003; 89: 2116-2121.